Your browser doesn't support javascript.
loading
The genomic imprint of cancer therapies helps timing the formation of metastases.
Németh, Eszter; Krzystanek, Marcin; Reiniger, Lilla; Ribli, Dezso; Pipek, Orsolya; Sztupinszki, Zsófia; Glasz, Tibor; Csabai, István; Moldvay, Judit; Szallasi, Zoltan; Szüts, Dávid.
Afiliación
  • Németh E; Institute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest, Hungary.
  • Krzystanek M; Translational Cancer Genomics, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Reiniger L; 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
  • Ribli D; SE-NAP Brain Metastasis Research group, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
  • Pipek O; Department of Physics of Complex Systems, Eötvös University, Budapest, Hungary.
  • Sztupinszki Z; Department of Physics of Complex Systems, Eötvös University, Budapest, Hungary.
  • Glasz T; Translational Cancer Genomics, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Csabai I; 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
  • Moldvay J; Department of Physics of Complex Systems, Eötvös University, Budapest, Hungary.
  • Szallasi Z; SE-NAP Brain Metastasis Research group, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
  • Szüts D; Department of Tumor Biology, National Korányi Institute of Pulmonology-Semmelweis University, Budapest, Hungary.
Int J Cancer ; 145(3): 694-704, 2019 08 01.
Article en En | MEDLINE | ID: mdl-30694556

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cisplatino / Impresión Genómica / Inhibidores de Proteínas Quinasas / Gefitinib / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Hungria

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Cisplatino / Impresión Genómica / Inhibidores de Proteínas Quinasas / Gefitinib / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Cancer Año: 2019 Tipo del documento: Article País de afiliación: Hungria